Integrating network pharmacology and experimental models to identify notoginsenoside R1 ameliorates atherosclerosis by inhibiting macrophage NLRP3 inflammasome activation.
Briefly

This website is for information purposes only. By providing the information contained herein, we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition.
Before beginning any type of natural, integrative, or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.
Read at Greenmedinfo
[
add
]
[
|
|
]